Drug intelligence / Profile preview

artemisinic acid

Development stage
Unknown
Lead developer
University of California, Berkeley
Modality
Small Molecules
01

Overview

Artemisinic acid is a plant-derived sesquiterpene carboxylic acid from *Artemisia annua* that serves primarily as a key biosynthetic precursor and semisynthetic starting material for the antimalarial drug artemisinin and related endoperoxide sesquiterpene lactones.[6][12][13] As a small-molecule natural product, it has been produced at scale via engineered yeast fermentation followed by chemical conversion to artemisinin to support global supply of artemisinin-based combination therapies for malaria.[11][13] Beyond its role as a precursor, artemisinic acid itself has been reported in preclinical studies to possess antimalarial, antibacterial, antitumor, and anti-inflammatory or antipyretic activities, but it is not an approved pharmaceutical and is mainly used as an intermediate or research tool compound.[12][15]

Other names
artemisic acid(+)-artemisinic acidqing hao acid
02

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)MMP2 (Matrix metalloproteinase-2)DNACEBPA (C/EBPα)

Beyond the preview

Go deeper on artemisinic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on artemisinic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call